Ovarian epithelial neoplasms
Ovarian epithelial neoplasms
Updated:08/12/2022
© Jun Wang, MD, PhD
General feature
- Most common type of ovarian tumor
- Derived from surface epithelium (mesothelium)
- Most important risk factor: Family history
- Other risk factors: Excessive gonadotropins, androgen stimulation, pelvic inflammation, ovarian exposure to contaminants and carcinogens (talc and asbestos), nulliparity, refractory infertility, obesity
- Subtypes
Seromucinous
Undifferentiated
Carcinogenesis
- Type I: Low-grade
Associated with borderline tumors or
endometriosis
Stepwise development from a lower grade
tumor
Chromosomally stable
- Type II: High-grade carcinomas
Rapidly growing
Usually wide spread at the time of diagnosis
No recognizable precursors
Largely variable DNA copy number
Clinical features
- Commonly asymptomatic if benign
- Abdominal enlargement, lower abdominal pain, etc
- Acute abdominal pain if torsion occurs
- Metastasis: Often contralateral ovary, pelvic peritoneum, umbilicus (Sister Joseph’s nodule)
Commonly used serum cancer markers
- CA125: Serous, endometrioid
- HE4: Serous, endometrioid, clear cell
- CEA: Mucinous
- Type I: KRAS (mucinous and low-grade serous), BRAF (low-grade serous), HER2 (mucinous), PTEN (endometrioid, clear cell), etc
- Type II (high-grade serous): p53, BRCA 1, BRCA 2
Syndromes associated with
ovarian epithelial tumors
- Hereditary Breast and Ovary Cancer syndrome: BRCA1 and BRCA2
- Lynch syndrome: DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2)
- Peutz-Jeghers syndrome: STK11
- Cowden syndrome: PTEN
- Coffin-Siris Syndrome: ARID1A
- Li-Fraumeni syndrome: p53
- Other germline mutations that are correlated to ovarian carcinoma affect BRIP1, CHEK2, RAD51
Reference: Tumor markers in ovarian malignancies
Back to pathology of ovary
Back to female genital tract
Back to contents
Comments
Post a Comment